Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Additional Paid-In Capital : €87.6 Mil(As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Additional Paid-In Capital?

Laboratorios Farmaceuticos Rovi's quarterly additional paid-in capital stayed the same from Sep. 2023 (€87.6 Mil) to Dec. 2023 (€87.6 Mil) and stayed the same from Dec. 2023 (€87.6 Mil) to Mar. 2024 (€87.6 Mil).

Laboratorios Farmaceuticos Rovi's annual additional paid-in capital stayed the same from Dec. 2021 (€87.6 Mil) to Dec. 2022 (€87.6 Mil) and stayed the same from Dec. 2022 (€87.6 Mil) to Dec. 2023 (€87.6 Mil).

Laboratorios Farmaceuticos Rovi Additional Paid-In Capital Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Additional Paid-In Capital Chart

Laboratorios Farmaceuticos Rovi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

87.64

Laboratorios Farmaceuticos Rovi Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															87.64	87.64	87.64	87.64	87.64

Laboratorios Farmaceuticos Rovi Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Laboratorios Farmaceuticos Rovi Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

ROVI:Mexico ROVIe:UK 41L:Germany

Address

Julian Camarillo, 35, Madrid, ESP, 28037

Website

https://www.rovi.es

Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.